Texas University Develops a Fentanyl Vaccine

Alice Giordano
NTD Newsroom
By Alice Giordano&NTD Newsroom
December 5, 2022USshare

A vaccine designed to fight opioid addiction has been developed.

Introduced as a fentanyl vaccine, it was created by a team of researchers at the University of Houston (UH) after years of research.

While still in clinical stages, the new vaccine is being touted by UH as a “game changer” for the world’s opioid crisis.

“We believe these findings could have a significant impact on a very serious problem plaguing society for years—opioid misuse,” said researcher Colin Haile in a Nov. 14 UH article announcing the vaccine.

A study on the vaccine’s development was recently published in Pharmaceutics journal.

According to Haile, the vaccine has shown promising lab results of developing anti-fentanyl antibodies capable of stopping the drug from entering the brain and thereby preventing users from getting a high off the opiod.

“Thus, the individual will not feel the euphoric effects and can ‘get back on the wagon’ to sobriety,” said Haile.

The vaccine, which is slated to be tested on humans in just a few months, has already drawn suspicion, with skeptics concerned that the vaccine is more of a back-door approach to using vaccines for mind control.

“The same people who flooded the country with fentanyl hope to make additional billions on vaccines that will supposedly solve the problem they caused. This is a tried-and-true business model for Big Pharma. You can’t make this stuff up.” said Robert F. Kennedy, Jr., founder of Children’s Health Defense in an article published this week in The Defender, his organization’s online publication.

China is the number one producer of fentanyl with the top culprits for its illegal importation into the United States being cartels from Mexico, where the Biden administration maintains an open border policy.

As Kennedy pointed out, development of the fentanyl vaccine was funded under a program run by the U.S. Department of Defense (DOD), which also provided major funding for the development of the COVID vaccine.

That program, called the Pharmacotherapies for Alcohol and Substance Use Disorders Alliance or (PASA), is made up of familiar organizations including the National Institutes of Health (NIH), which oversees Anthony Fauci’s National Institute of Allergy and Infectious Diseases (NIAID). It also includes the Scripps Research Institute, which received millions of dollars from the Bill and Melinda Gates Foundation, which was deeply financially involved in promoting the COVID vaccine.

In addition to being a professor at the University of Houston, Haile also is part of the University’s Texas Institute for Measurement, Evaluation and Statistics, which lists the DOD, NIH, and CDC (Centers for Disease Control and Prevention) among its main sponsors.

Much like the multiple boosters said to be necessary in order for the COVID vaccine to be effective, UH’s fentanyl vaccine will have to be administered three times to be effective.

The idea behind preventing fentanyl from reaching the brain is that it will prevent addiction or help an addict wean off the drug.

However, people involved in opioid treatment posted comments online expressing concern that the fentanyl-exclusive vaccine will only push addicts onto another drug.

“This is insane–why not a vaccine for heroin, crack, meth?,” wrote one woman who works with transitioning convicted drug users back into society after they have served their jail time. “As someone who’s lost clients to all of these drugs, I’m aware of how you can market this, but why anyone would think blocking a high for one drug would address addiction is beyond me. These corporate drug dealers are worse than the street dealers!!”

According to the CDC, about 150 people die daily from an overdose of opiod, mostly fentanyl, which is considered 50 times stronger than heroin and 100 times stronger than morphine.

From The Epoch Times

ntd newsletter icon
Sign up for NTD Daily
What you need to know, summarized in one email.
Stay informed with accurate news you can trust.
By registering for the newsletter, you agree to the Privacy Policy.
Comments